CLINICAL_TRIALS
ClinicalTrials.gov record update
Frequency and Abundance of ALK/ROS1/MET Mutations on Circulating Tumor DNA in Patients With Non-small Cell Lung Cancer Using Single Molecule Amplifcation and Re-sequencing Technology: a Perspective Observational Study
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT02946216
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:36:23.660849+00:00
- Published At
- 2016-10-27T00:00:00+00:00
- Record Updated At
- 2016-10-27
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Non-small Cell Lung Cancer Stage III", "Non-Small-Cell Lung Cancer Metastatic", "Adenocarcinoma of Lung", "EGFR Wildtype"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2016-10-27"- protocolSection.identificationModule.nctId
"NCT02946216"- protocolSection.identificationModule.officialTitle
"Frequency and Abundance of ALK/ROS1/MET Mutations on Circulating Tumor DNA in Patients With Non-small Cell Lung Cancer Using Single Molecule Amplifcation and Re-sequencing Technology: a Perspective Observational Study"- protocolSection.statusModule.overallStatus
"UNKNOWN"- protocolSection.designModule.phases
[]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.